From 'Artificial Intelligence' to 'Intelligence Augmentation'... the fusion of AI, sensors, and robotics is rapidly being developed across the healthcare continuum, from diagnostics to therapy selection, drug development and surgery.

The eagerly awaited EMJ Interventional Cardiology 6.1, offering a comprehensive and independent review of EuroPCR 2018, is now available for all to enjoy.

The congress, which took place in Paris, France, is the progeny of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and represents a world-leading course in interventional cardiovascular medicine.

10th July 2018

US and European regulators to attend the world's first large-scale global summit dedicated to AI in healthcare

Intelligent Health, Basel, Switzerland, 12-13 September 2018

The US Food and Drug Administration (FDA) and The European Commission have confirmed attendance at the world's first large-scale global summit dedicated to AI in healthcare taking place this September in Basel, Switzerland.

The event will gather the entire global AI health ecosystem of pharmaceutical, biotech, medtech, health provision, clinicians, insurance, investment and science, some of the biggest national hospitals and health systems in Europe, the world’s largest pharmaceutical companies and the top health regulator on AI in the US.